Resultados de la búsqueda 401-410 of 14025 for melatonin receptor agonists

  1. Cirugía - Ensayos clínicos - Mayo Clinic

    This randomized phase II/III trial studies how well radiation therapy works when given together with cisplatin compared to docetaxel or cetuximab and ...

  2. Cirugía - Ensayos clínicos - Mayo Clinic

    Some patients undergoing trigger finger surgery with a pre-existing Dupuytren's cord may develop a thickened surgical scar after surgery, which can cause ...

  3. Cirugía - Ensayos clínicos - Mayo Clinic

    This is a prospective, non-randomized, single center, data collection study of patients treated with open surgical repair (OR) for complex aortic aneurysms ( ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to develop preclinical models that include cell lines and patient derived xenografts (PDX) that include molecular ...

  5. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to determine freedom from ipsilateral breast recurrence occurrences in patients receiving partial breast proton radiation therapy ...

  6. Radiología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to address a knowledge gap. Early diagnosis of nerve root avulsion injuries following brachial plexus trauma remain a barrier to ...

  7. Neurología - Ensayos clínicos - Mayo Clinic

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status,, and HER2 negative/ER positive), (5) advanced, unresectable colorectal cancer ...

  8. Hematología - Ensayos clínicos - Mayo Clinic

    ... receptor (ER and PR) all negative], HER2 positive whatever the ER/PR status ... Avelumab In Combination Regimens That Include An Immune Agonist ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    Romidepsin and lenalidomide may stop the growth of cancer cells by blocking enzymes needed for cell growth. Giving rituximab together with romidepsin and ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as obinutuzumab, may ...